Discontinuation report ELOXATIN

Last updated on 2018-10-24 History
Report ID 57613
Drug Identification Number 02296284
Brand name ELOXATIN
Common or Proper name Eloxatin Solution 100mg/20ml
Company Name SANOFI-AVENTIS CANADA INC
Market Status CANCELLED POST MARKET
Active Ingredient(s) OXALIPLATIN
Strength(s) 5MG
Dosage form(s) SOLUTION
Route of administration INTRAVENOUS
Packaging size 1
ATC code L01XA
ATC description OTHER ANTINEOPLASTIC AGENTS
Reason for discontinuation Business reasons
Anticipated discontinuation date 2018-10-19
Actual discontinuation date 2018-10-19
Remaining supply date 2018-10-19
Discontinuation status Discontinued
Discontinuation decision reversal No
Information on remaining supply
Company comments
Health Canada comments
Tier 3 Status No
Company contact information email: CAINTERNET@sanofi.com Telephone: 1-800-265-7927

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v1 2018-08-07 English Compare
v2 2018-08-07 French Compare
v3 2018-08-29 English Compare
v4 2018-08-29 French Compare
v5 2018-08-29 English Compare
v6 2018-08-29 French Compare
v7 2018-10-24 English Compare
v8 2018-10-24 French Compare

Showing 1 to 8 of 8